Related Experiment Video
Updated: Aug 6, 2026

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
[Nonsteroidal antiinflammatory drugs and nitric oxide]
Edward Kowalczyk1, Anna Kopff, Jan Błaszczyk
1Uniwersytet Medyczny w Lodzi, Zakład Fizjologii Człowieka i Biofizyki. farmak@achilles.wam.lodz.pl
Unlabelled:
Despite of belonging to different chemical groups all nonsteroidal antiinflammatory drugs (NSAIDs) exert on antiinflammatory, antypyretic and analgetic effects inhibiting prostaglandin synthesis, preciseley inhibiting first enzyme in arachidonic acid- cyclooxygenase. The aim of the study was to investigate the influence of NSAIDs on nitric oxide synthesis and releasing to bloodstream Acetylsalicic acid (ASA) and diclofenac as COX-1 and COX-2 inhibitors and nimesulide as selective COX-2 inhibitor were used in study.
Material And Methods:
An experiment was carried out on male Wistar rats administered intragastrically with acetylsalicylic acid in doses: 2.0 and 10.0 mg/kg of body weigh, diclofenac in doses: 1.0 and 5.0 mg/kg body weigh and nimesulide in doses: 2.5 and 12.5 mg/kg body weigh for three weeks. Results compared to control group which received water instead of achive drugs. Nitric oxide was determined by Nitric Oxide Non-Enzymatic Assay of Oxis International.
Results:
ASA and nimesulide use did not significantly influence NO plasma concentration. Diclofenac administration at the 1.0 and 5.0 mg/kg of body weigh was associated with increased NO concentration by 48.7% and 73.5% respectively.
Conclusion:
NO concentration is not relevant to selective or non selective inhibition of COX by NSAIDs. ASA (a non selective NSAIDs) and nimesulide (sective NSAIDs) do not influence NO concentration, while diclofenac (non selective NSAIDs) causes an increase in NO blood concentration in rats.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Angina IV: Management

